[Use of anabolic hormones for the treatment of cardiovascular patients].
D045930:Anabolic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000728:Androgens; D000818:Animals; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D002087:Butyrates / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D003327:Coronary Disease / Q000188:drug therapy; D003331:Coronary Vessels / Q000187:drug effects; D006321:Heart / Q000187:drug effects; D006329:Heart Conduction System / Q000187:drug effects; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008099:Liver / Q000187:drug effects; D008107:Liver Diseases / Q000188:drug therapy; D008696:Methandrostenolone / Q000627:therapeutic use; D008710:Methenolone / Q000627:therapeutic use; D008777:Methyltestosterone / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D008956:Models, Chemical; D009203:Myocardial Infarction / Q000188:drug therapy; D009277:Nandrolone / Q000494:pharmacology / Q000627:therapeutic use; D009639:Norethandrolone / Q000494:pharmacology; D011422:Propionates; D013739:Testosterone / Q000494:pharmacology / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use; D014882:Water-Electrolyte Balance / Q000187:drug effects
D045930:Anabolic Agents; D000728:Androgens; D000924:Anticholesteremic Agents; D002087:Butyrates; D011422:Propionates; D014665:Vasodilator Agents; D013739:Testosterone; D009277:Nandrolone; D008710:Methenolone; D008696:Methandrostenolone; D009639:Norethandrolone; D008777:Methyltestosterone
Primenenie anabolicheskikh gormonov dlia lecheniia serdechno-sosudistykh bol'nykh.